 Five Johns Hopkins Kimmel Cancer Researchers Called Best in Their FieldKimmel Cancer Center Called Research Powerhouse
Scientific journals are researchers' way of disseminating key findings throughout the medical community. Rather than starting from scratch, investigators build upon published discoveries of others. In cancer research, the "others" are most often five Kimmel Cancer Center investigators, according to the January/February issue of Science Watch, a newsletter published by Thomson Scientific. With more than 90,000 references between them, investigators Bert Vogelstein, M.D., Kenneth Kinzler, Ph.D., James Herman, M.D., Stephen Baylin, M.D., and David Sidransky, M.D., were named in the newsletter as the most frequently cited in cancer research from 1999-2005.
 Abdominal Chemo Boosts Survival in Ovarian Cancer PatientsStudy Led by Johns Hopkins Kimmel Cancer Center Suggests New Treatment Standard for Advanced Disease
A 50-year-old method for delivering chemotherapy directly into the abdomen is making a comeback as investigators have found that it increases survival - by more than a year - in some women with advanced ovarian cancer. Results from a seven-year study of more than 400 patients nationwide are published in the January 5 issue of the New England Journal of Medicine.
 Dendritic Cells Offer New Therapeutic Target for Drugs to Treat MS and Other Autoimmune DiseaseScientists at the Johns Hopkins Kimmel Cancer Center have found that a gene pathway linked to a deadly form of leukemia may provide a new way to treat autoimmune diseases, including multiple sclerosis. Their tests in cell cultures and mice suggest that blocking the pathway by interfering with a blood cell growth gene, known as FLT3, targets an immune system cell often ignored in favor of T-cell targets in standard therapies.
 Inventing Cancer CuresThough no doctor could cure his wife with today's medicine, inventor Robert E. Fischell wants to change that for tomorrow's cancer patients. He has given leukemia specialist Judy Karp $1 million to develop new cures that may someday revolutionize cancer research.
|
